Social cognitive endophenotypes in schizophrenia: A study comparing first episode schizophrenia patients and, individuals at clinical- and familial- 'at-risk' for psychosis

被引:21
|
作者
Tikka, Deyashini Lahiri [1 ,3 ]
Singh, Amool Ranjan [1 ]
Tikka, Sai Krishna [2 ]
机构
[1] Ranchi Inst Neuro Psychiat & Allied Sci, Dept Clin Psychol, Ranchi 834006, Jharkhand, India
[2] All India Inst Med Sci, Dept Psychiat, Raipur 492099, Chhattisgarh, India
[3] Postgrad Inst Behav & Med Sci, Dept Clin Psychol, Raipur 492001, Chhattisgarh, India
关键词
Theory of mind; Social perception; Emotion recognition; Neurocognition; ULTRA-HIGH RISK; 2 QUANTITATIVE INDICATORS; 1ST-DEGREE RELATIVES; DETECTING TAXONICITY; TAXOMETRIC ANALYSIS; DEFICITS; NEUROCOGNITION; SYMPTOMS; SCALE; MIND;
D O I
10.1016/j.schres.2019.10.053
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Impairments in specific domains of social cognition have been suggested as possible endophenotypes for schizophrenia and clinical markers for accurate identification of 'at-risk' (AR) states. Aim of the present study was to find out whether performance on social cognition tasks will distinguish 'clinical at-risk (CAR)' and 'familial at-risk (FAR)' individuals from remitted first episode schizophrenia (FES) patients and healthy controls. Fifty in each of these four groups were included for analysis. Schizophrenia psychopathology in FES group was assessed using the Positive and Negative Syndrome Scale (PANSS). Theory of mind (ToM; first and second order (SOT and FOT), and faux pas composite (FPC)), attributional bias (AB) and social perception (SP) were assessed using the Social Cognition Rating Tool in Indian Setting (SOCRATIS). Facial emotion recognition task was used to assess emotional-expression recognition (ER). Significant differences in ToM, SP and ER between the four groups were found, even after controlling for performance on various neurocognitive tasks. ToM and SP were identified to follow an endophenotype pattern. While, both ToM and SP classified FES from healthy with large accuracy rates, SP, specifically, distinguished at-risk from disease groups. None of the social cognitive domains accurately classified familial at-risk from clinical at-risk groups. We conclude that social cognitive measures may be used as reliable endophenotype markers for schizophrenia and its sub-domains may be used for valid identification of AR individuals. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 50 条
  • [41] Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study
    Heeramun-Aubeeluck, Anisha
    Liu, Na
    Fischer, Felix
    Huang, Nan
    Chen, Fazhan
    He, Leiying
    Yang, Chengqing
    Luo, Yanli
    Lu, Zheng
    NORDIC JOURNAL OF PSYCHIATRY, 2015, 69 (04) : 254 - 261
  • [42] Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia
    Le, Anh Thi Phuong
    Higuchi, Yuko
    Sumiyoshi, Tomiki
    Itoh, Hiroko
    Sasabayashi, Daiki
    Takahashi, Tsutomu
    Suzuki, Michio
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [43] COMPARISON OF CLINICAL ROUTINE EEG AND QUANTITATIVE EEG IN FIRST EPISODE OF PSYCHOSIS AND AT-RISK MENTAL STATE INDIVIDUALS
    Pflueger, Marlon O.
    Gschwandtner, Ute
    Zimmermann, Ronan
    Gaggiotti, Manuela
    Semenin, Vitaliy
    Riecher-Roessler, Anita
    Fuhr, Peter
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 364 - 365
  • [44] Schizophrenia Polygenic Risk Score Predicts Antipsychotic Treatment Response in Patients With First Episode Psychosis
    Zhang, Jianping
    Robinson, Delbert
    Yu, Jin
    Fleischhacker, Wolfgang
    Kahn, Rene
    Kane, John
    Malhotra, Anil
    Lencz, Todd
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S569 - S570
  • [45] SCHIZOPHRENIA POLYGENIC RISK SCORE PREDICTS ANTIPSYCHOTIC TREATMENT RESPONSE IN PATIENTS WITH FIRST EPISODE PSYCHOSIS
    Zhang, Jianping
    Robinson, Delbert
    Yu, Jin
    Gallego, Juan
    Fleischhacker, W. Wolfgang
    Kahn, Rene S.
    Crespo-Facorro, Benedicto
    Vazquez-Bourgon, Javier
    Kane, John
    Malhotra, Anil
    Lencz, Todd
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S999 - S999
  • [46] Mobile Cognitive Training in Individuals at Clinical High Risk for Psychosis and with Recent-onset Schizophrenia
    Loewy, Rachel
    Fisher, Melissa
    Carter, Cameron
    Ragland, J. Daniel
    Niendam, Tara
    Stuart, Barbara
    Schlosser, Danielle
    Vinogradov, Sophia
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 : 74 - 74
  • [47] Predictors of social and role functioning in people at high risk for psychosis, first episode of schizophrenia, and healthy controls
    Wojcik, Joanne D.
    Mesholam-Gately, Raquelle I.
    Woodberry, Kristen A.
    Cousins, Ann
    Gnong-Granato, Andrea
    Friedman-Yakoobian, Michelle
    Rodenheiser-Hill, Janine
    Hornbach, Sarah
    Serur, Rachael
    Min, Grace
    Francis, Grace
    Tucker, Lynda
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 40 - 40
  • [48] Stressful life events, appraisal, and coping in individuals at clinical high-risk for psychosis, first-episode schizophrenia and healthy controls
    Lannon, Edward
    Alderman, Tracy
    Gerwer, Johanna
    Cadenhead, Kristin
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 66 - 66
  • [49] Progressive reduction of auditory evoked gamma in first episode schizophrenia but not clinical high risk individuals
    Oribe, Naoya
    Hirano, Yoji
    del Re, Elisabetta
    Seidman, Larry J.
    Mesholam-Gately, Raquelle I.
    Woodberry, Kristen A.
    Wojcik, Joanne D.
    Ueno, Takefumi
    Kanba, Shigenobu
    Onitsuka, Toshiaki
    Shenton, Martha E.
    Goldstein, Jill M.
    Niznikiewicz, Margaret A.
    McCarley, Robert W.
    Spencer, Kevin M.
    SCHIZOPHRENIA RESEARCH, 2019, 208 : 145 - 152
  • [50] INFLUENCE OF SCHIZOPHRENIA POLYGENIC RISK SCORES ON BRAIN SURFACE: AN EXPLORATORY STUDY IN FIRST EPISODE OF PSYCHOSIS
    del Carmen Garcia-Gonzalez, Maria
    Papiol, Sergi
    Vazquez-Bourgon, Javier
    Ayesa-Arriola, Rosa
    Setien-Suero, Esther
    Ortiz-Garcia de la Foz, Victor
    Fananas, Lourdes
    Crespo-Facorro, Benedicto
    Tordesillas-Gutierrez, Diana
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1139 - 1139